Related Experiment Video
Updated: Jun 21, 2026

10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Tuberculosis in Czech Republic in the year 2007]
J Homolka1, F Krejbich, J Holub
1Univerzita Karlova v Praze, 1. lékarská fakulta, I klinika tuberkulózy a respiracních nemocí VFN. jhomolka@cesnet.cz
Casopis Lekaru Ceskych
|August 1, 2009
Summary
Tuberculosis incidence in the Czech Republic continued to decline in 2007, with 871 cases reported. Future control efforts should focus on active case-finding in high-risk populations and latent tuberculosis infection monitoring.
Area of Science:
- Public Health
- Epidemiology
- Infectious Diseases
Context:
- The Czech Republic observed a decrease in notified tuberculosis (TB) cases in 2007.
- A total of 871 new TB cases and relapses were reported, representing an incidence of 8.4 per 100,000 inhabitants.
- This continued a decreasing trend in TB incidence observed since 1998.
Purpose:
- To analyze the epidemiological trends of tuberculosis in the Czech Republic for the year 2007.
- To identify key areas for future tuberculosis control strategies.
Summary:
- Pulmonary tuberculosis accounted for 744 cases (7.2/100,000), with 506 definite pulmonary cases (4.9/100,000).
- In 2007, 266 smear-positive pulmonary tuberculosis cases were diagnosed.
- Active case-finding identified only 14.7% of new pulmonary TB cases, highlighting a gap in detection.
Impact:
- The findings underscore the need for enhanced active case-finding strategies targeting high-risk groups.
- Monitoring latent tuberculosis infection is crucial for comprehensive TB control.
- The study provides data to inform public health policy and resource allocation for tuberculosis elimination efforts in the Czech Republic.
Related Concept Videos
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
